<?xml version="1.0" encoding="UTF-8"?>
<p>Relatively few documents reviewed revealed financial information relating specifically to the response to 90–90–90. In most cases costs cited were associated with the policy change for treating all PLHIV irrespective of CD4 cell count as per the WHO 2015 ART guidelines—a policy change considered critical to the attainment of 90–90–90 (herein referred to as ‘test and treat’). Thus perceptions on how the targets had influenced the HIV programme budget were obtained from informants.</p>
